Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn (Q34823987)

4 August 2017

1 reference

title

Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn (English)

1 reference

4 August 2017

Andrew G Hadley

1

1 reference

4 August 2017

publication date

1 August 2002

1 reference

4 August 2017

published in

Transplant Immunology

1 reference

4 August 2017

volume

10

1 reference

4 August 2017

issue

2-3

1 reference

4 August 2017

page(s)

191-198

1 reference

Production of additional atypical alloantibodies in Rh(D)-sensitized pregnancies managed by intrauterine investigation methods

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Maternal serum anti-D antibody concentration and assessment of rhesus isoimmunisation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Detection of fetal erythrocytes in maternal blood post partum with the fluorescence-activated cell sorter

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

The prevention of Rh immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Plasmapheresis in Rh hemolytic disease: the danger of amniocentesis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Induction of additional red cell alloantibodies after intrauterine transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

The effect of Rh genotypes on severity in haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

HLA phenotypes and severe Rh(D) immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Human IgG subclasses in maternal and fetal serum

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Elevation of Cord over Maternal IgG Immunoglobulin: Evidence for an Active Placental IgG Transport

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Anti-D Concentration in Mother and Child in Haemolytic Disease of the Newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Transplacental IgG subclass concentrations in pregnancies at risk of haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Short communication: selective placental transport of maternal IgG to the fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Molecular basis of Fc receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Functional interactions of red cells sensitized by IgG1 and IgG3 human monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Blockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. III. Comparison of IgG anti-D agglutinating and lytic (ADCC) activity and the role of IgG subclasses

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Anti-Rh(D) IgG subclasses and severity of Rh hemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Immunoglobulin G subclasses and isoimmunized pregnancy outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Mononuclear phagocyte assays, autoanalyzer quantitation and IgG subclasses of maternal anti-RhD in the prediction of the severity of haemolytic disease in the fetus before 32 weeks gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

IgG subclasses and Gm allotypes of anti-D antibodies during pregnancy: correlation with the gravity of the fetal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Correlation of IgG subclass with the severity of hemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Serological and immunological characteristics of maternal anti-Rh(D) antibodies in predicting the severity of haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Anti-D concentrations in fetal and maternal serum and amniotic fluid in rhesus allo-immunised pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Erythropoietic suppression in fetal anemia because of Kell alloimmunization

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Misleading results in the determination of haemolytic disease of the newborn using antibody titration and ADCC in a woman with anti-Lub

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with ABO haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Molecular basis for a polymorphism of human Fc gamma receptor II (CD32)

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR)

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Monocyte-bound monoclonal antibodies inhibit the Fc gamma RI-mediated phagocytosis of sensitized red cells: the efficiency and mechanism of inhibition are determined by the nature of the antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Papain-treated red cells in the detection of incomplete antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

A prospective study of routine antenatal enzyme antibody screening demonstrates lack of clinical value in predicting haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Red cell antibodies in pregnancy: there is no 'critical titre'

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

ADCC and other cellular bioassays for predicting the clinical significance of red cell alloantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Manipulative and inherent errors in anti-D quantitation using the AutoAnalyzer

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Use of Discriminant Analysis in Relating Maternal Anti-D Levels to the Severity of Haemolytic Disease of the Newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

The role of Rh antibodies in haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Prediction of the outcome of rhesus haemolytic disease of the newborn: additional information using an ADCC assay

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Bioassays to determine the clinical significance of red cell alloantibodies based on Fc receptor-induced destruction of red cells sensitized by IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Monocyte monolayer assay: an efficient noninvasive technique for predicting the severity of hemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus and newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

Predicting the severity of rhesus alloimmunization: monocyte-mediated chemiluminescence versus maternal anti-D antibody estimation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

In vitro assays to predict the severity of hemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900065-5

7 January 2021

10.1016/S0966-3274(02)00065-5

Identifiers

DOI

1 reference

4 August 2017

1 reference